Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges

Along with the evolution of immunophenotypic and molecular diagnostics, the assessment of Minimal Residual Disease (MRD) has progressively become a keystone in the clinical management of hematologic malignancies, enabling valuable post-therapy risk stratifications and guiding risk-adapted therapeuti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2021-09, Vol.13 (18), p.4582
Hauptverfasser:	Riva, Giovanni, Nasillo, Vincenzo, Ottomano, Anna Maria, Bergonzini, Giuliano, Paolini, Ambra, Forghieri, Fabio, Lusenti, Beatrice, Barozzi, Patrizia, Lagreca, Ivana, Fiorcari, Stefania, Martinelli, Silvia, Maffei, Rossana, Marasca, Roberto, Potenza, Leonardo, Comoli, Patrizia, Manfredini, Rossella, Tagliafico, Enrico, Trenti, Tommaso, Luppi, Mario
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute lymphoblastic leukemia Acute myeloid leukemia Antigens Blood diseases Bone marrow Chronic lymphocytic leukemia Cloning Decision making Flow cytometry Genomes Genotype & phenotype Immunotherapy Leukemia Lymphatic leukemia Lymphocytes T Minimal residual disease Multiple myeloma Next-generation sequencing Patients Peripheral blood Precision medicine Remission (Medicine) Review Standardization Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!